Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUniphar Regulatory News (UPR)

Share Price Information for Uniphar (UPR)

Share Price is delayed by 15 minutes
Get Live Data
395.00    -7.00 (-1.74%)
Bid:
390.00
Ask:
400.00
Spread: 10.00 (2.564%)
Market Cap: £1.03b
UPR Live PriceLast checked at - London Stock Exchange

Intraday Uniphar Share Chart

Holding(s) in Company

14 Sep 2023 15:00

RNS Number : 5019M
Uniphar PLC
14 September 2023
 

Standard Form TR-1 Voting rights attached to shares- Article 12(1) of directive 2004/109/ECFinancial instruments - Article 11(3) of the Commission Directive 2007/14/EC[i]

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached [ii]:

UNIPHAR PLC

2. Reason for the notification (please tick the appropriate box or boxes):

[ X ] an acquisition or disposal of voting rights

[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

[ ] an event changing the breakdown of voting rights

3. Full name of person(s) subject to the notification obligation[iii]:

BlackRock, Inc.

4. Full name of shareholder(s) (if different from 3.)[iv]:

See Section 9

5. Date of the transaction and date on which the threshold is crossed or reached[v]: 13/09/2023

6. Date on which issuer notified: 14/09/2023

7. Threshold(s) that is/are crossed or reached:

Holdings for BlackRock, Inc. have gone below 3%.

8. Notified details:

1.

1. 1. 1.

A) Voting rights attached to shares

Class/type of shares (if possible using the ISIN CODE)

Situation previous to the Triggering transaction [vi]

Resulting situation after the triggering transaction[vii][viii]

Number of Shares[ix]

Number of Voting rights[x]

Number of shares[xi]

Number of voting rights[xii]

% of voting rights

Direct

Direct[xiii]

Indirect[xiv]

Direct

Indirect

IE00BJ5FQX74

N/A

8,205,205

N/A

N/A

Below3%

N/A

Below3%

SUBTOTAL A (based on aggregate voting rights)

Below3%

Below3%

 

B) Financial Instruments

Resulting situation after the triggering transaction[xv]

Type of financial instrument

Expiration Date[xvi]

Exercise/Conversion Period/ Date[xvii]

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

SUBTOTAL B (in relation to all expiration dates)

 

Total (A+B)

number of voting rights

% of voting rights

Below3%

Below3%

Below3%

 

9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable[xviii]:

 

Each of the following entities, which are wholly owned subsidiaries of BlackRock, Inc., hold the following interests in voting rights in their capacity as Investment Manager on behalf of clients:

Investment Manager

Voting Rights

%

BlackRock Advisors (UK) Limited

Below 3%

Below 3%

BlackRock Asset Management Canada Limited

Below 3%

Below 3%

BlackRock Fund Advisors

Below 3%

Below 3%

BlackRock Institutional Trust Company, National Association

Below 3%

Below 3%

BlackRock Investment Management (UK) Limited

Below 3%

Below 3%

BlackRock Investment Management, LLC

Below 3%

Below 3%

 

 

10. In case of proxy voting: [name of the proxy holder] will cease to hold [number] voting rights as of [date].

11. Additional information:

Decrease in holding following client instruction to elect for decision making on voting rights.

Done at 12 Throgmorton Avenue, London, EC2N 2DL, U.K. on 14 September 2023

 

 


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLNKQBQNBKDPCD
Date   Source Headline
2nd Jun 20267:00 amRNSChange of Nominated Adviser
15th May 20267:00 amRNSDirector/PDMR Shareholding
7th May 20263:32 pmRNSAGM Results
7th May 20267:00 amRNSAGM Statement
30th Apr 20265:41 pmRNSHolding(s) in Company
29th Apr 20267:00 amRNSHolding(s) in Company
28th Apr 20265:38 pmRNSHolding(s) in Company
13th Apr 20267:00 amRNSExecutive Restricted Share Plan Dealings
7th Apr 202611:07 amRNSHolding(s) in Company
2nd Apr 202611:12 amRNSHolding(s) in Company
1st Apr 20267:00 amRNSNotice of AGM & Annual Report
27th Mar 202612:00 pmRNSHolding(s) in Company
19th Mar 20262:44 pmRNSHolding(s) in Company
17th Mar 20263:35 pmRNSHolding(s) in Company
12th Mar 202611:59 amRNSHolding(s) in Company
10th Mar 20261:30 pmRNSHolding(s) in Company
25th Feb 20262:45 pmRNSHolding(s) in Company
25th Feb 20262:45 pmRNSHolding(s) in Company
24th Feb 20267:00 amRNS2025 Preliminary Results
29th Jan 202612:45 pmRNSHolding(s) in Company
27th Jan 20267:00 amRNSFull Year Trading Update and Notice of Results
6th Jan 20263:39 pmRNSHolding(s) in Company
17th Dec 20252:22 pmRNSHolding(s) in Company
16th Dec 202512:03 pmRNSHolding(s) in Company - Replacement
12th Dec 20251:15 pmRNSDirector/PDMR Shareholding
10th Dec 20253:40 pmRNSHolding(s) in Company
28th Nov 20252:14 pmRNSHolding(s) in Company
27th Nov 202512:01 pmRNSHolding(s) in Company
25th Nov 20257:00 amRNSHolding(s) in Company
13th Nov 20257:00 amRNSDirector/PDMR Shareholding
11th Nov 202512:06 pmRNSHolding(s) in Company
24th Oct 202511:59 amRNSHolding(s) in Company
2nd Sep 20257:00 amRNS2025 Interim Results
29th Jul 20257:00 amRNSHalf Year Trading Update and Notice of Results
12th Jun 20254:45 pmRNSHolding(s) in Company
27th May 20252:15 pmRNSHolding(s) in Company
12th May 20252:52 pmRNSDirector/PDMR Shareholding
8th May 20252:09 pmRNSAGM Results
8th May 20259:45 amRNSHolding(s) in Company
8th May 20257:00 amRNSAGM Statement
7th Apr 20254:34 pmRNSHolding(s) in Company
3rd Apr 20257:01 amRNSNotice of AGM & Annual Report
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20254:10 pmRNSHolding(s) in Company
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20252:30 pmRNSHolding(s) in Company
5th Mar 20252:30 pmRNSHolding(s) in Company
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.